Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News SCAI 2025

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

L.A. McKeown

May 02, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

Presentation TVT 2017

TAVR in Perspective Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon

June 15, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

Presentation TVT 2017

Early Preclinical Experience of Aortic Valve-In-Ring Procedure

Presenter: Juan F. Granada, Martin B. Leon, Gregg W. Stone, Martin Andreas, MD

June 14, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

Presentation TCT 2016

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

Presentation ESC 2015

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Presenter: Gregg W. Stone

August 30, 2015

News Daily News

MVARC文件提供了二尖瓣治疗研究的模板

Todd Neale

July 16, 2015

Advertisement

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

TAVR in Perspective Evolution, Impact, and Future Expectations

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Early Preclinical Experience of Aortic Valve-In-Ring Procedure

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

MVARC文件提供了二尖瓣治疗研究的模板

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content